Population pharmacokinetics of propofol:: A multicenter study

被引:309
作者
Schüttler, J [1 ]
Ihmsen, H [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany
关键词
age; body weight; children; elderly; NONMEM;
D O I
10.1097/00000542-200003000-00017
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background Target-controlled infusion is an increasingly common type of administration for propofol. This method requires accurate knowledge of pharmacokinetics, including the effects of age and weight. The authors performed a multicenter population analysis to quantitate the effects of covariates. Methods: The authors analyzed 4,112 samples of 270 individuals (150 men, 120 women, aged 2-88 yr, weighing 12-100 kg). Population pharmacokinetic modeling was performed using NONMEM (NONMEM Project Group, University of California, san Francisco, CA). Inter- and intraindividual variability was estimated for clearances and volumes. The effects of age, weight, type of administration and sampling site were investigated. Results: The pharmacokinetics of propofol were best described by a three-compartment model. Weight was found to be a significant covariate for elimination clearance, the two intercompartmental clearances, and the volumes of the central compartment, the shallow peripheral compartment, and the deep peripheral compartment; power functions with exponents smaller than 1 yielded the best results. The estimates of these parameters for a 70-kg adult were 1.44 l/min, 2.25 l/min, 0.92 l/min, 9.3 l, 44.2 l, and 266 l, respectively. For patients older than 60 yr the elimination clearance decreased Linearly. The volume of the central compartment decreased with age. For children, all parameters were increased when normalized to body weight. Venous data showed a decreased elimination clearance; bolus data were characterized by increases in the volumes of the central and shallow peripheral compartments and in the rapid distribution clearance (Cl-2) and a decrease in the slow distribution clearance (Cl-3). Conclusions: Pharmacokinetics of propofol can be well described by a three-compartment model. Inclusion of age and weight as covariates significantly improved the model. Adjusting pharmacokinetics to the individual patient should improve the precision of target-controlled infusion and may help to broaden the field of application for target-controlled infusion systems.
引用
收藏
页码:727 / 738
页数:12
相关论文
共 39 条
[1]   PHARMACOKINETICS OF LONG-TERM PROPOFOL INFUSION USED FOR SEDATION IN ICU PATIENTS [J].
ALBANESE, J ;
MARTIN, C ;
LACARELLE, B ;
SAUX, P ;
DURAND, A ;
GOUIN, F .
ANESTHESIOLOGY, 1990, 73 (02) :214-217
[2]   Pharmacokinetics of propofol in adult patients undergoing coronary revascularization [J].
Bailey, JM ;
Mora, CT ;
Shafer, SL .
ANESTHESIOLOGY, 1996, 84 (06) :1288-1297
[3]   PHARMACOKINETICS OF PROPOFOL DURING AND AFTER LONG-TERM CONTINUOUS INFUSION FOR MAINTENANCE OF SEDATION IN ICU PATIENTS [J].
BAILIE, GR ;
COCKSHOTT, ID ;
DOUGLAS, EJ ;
BOWLES, BJM .
BRITISH JOURNAL OF ANAESTHESIA, 1992, 68 (05) :486-491
[4]  
BEAL SL, 1998, NONMEM USERS GUIDE
[5]   INDUCTION OF ANESTHESIA WITH PROPOFOL USING A TARGET-CONTROLLED INFUSION SYSTEM [J].
CHAUDHRI, S ;
WHITE, M ;
KENNY, GNC .
ANAESTHESIA, 1992, 47 (07) :551-553
[6]   PHARMACOKINETICS OF PROPOFOL IN FEMALE-PATIENTS - STUDIES USING SINGLE BOLUS INJECTIONS [J].
COCKSHOTT, ID ;
BRIGGS, LP ;
DOUGLAS, EJ ;
WHITE, M .
BRITISH JOURNAL OF ANAESTHESIA, 1987, 59 (09) :1103-1110
[7]  
COCKSHOTT ID, 1985, POSTGRAD MED J, V61, P45
[8]   PHARMACOKINETIC MODEL SELECTION FOR TARGET CONTROLLED INFUSIONS OF PROPOFOL - ASSESSMENT OF 3 PARAMETER SETS [J].
COETZEE, JF ;
GLEN, JB ;
WIUM, CA ;
BOSHOFF, L .
ANESTHESIOLOGY, 1995, 82 (06) :1328-1345
[9]   PROPOFOL CONCENTRATION MONITORING IN PLASMA OR WHOLE-BLOOD BY GAS-CHROMATOGRAPHY AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
FAN, SZ ;
YU, HY ;
CHEN, YL ;
LIU, CC .
ANESTHESIA AND ANALGESIA, 1995, 81 (01) :175-178
[10]  
Fechner J, 1998, ANAESTHESIST, V47, P663, DOI 10.1007/s001010050611